Literature DB >> 25741989

Focal embolic cerebral ischemia in the rat.

Li Zhang1, Rui Lan Zhang1, Quan Jiang1, Guangliang Ding1, Michael Chopp2, Zheng Gang Zhang1.   

Abstract

Animal models of focal cerebral ischemia are well accepted for investigating the pathogenesis and potential treatment strategies for human stroke. Occlusion of the middle cerebral artery (MCA) with an endovascular filament is a widely used model to induce focal cerebral ischemia. However, this model is not amenable to thrombolytic therapies. As thrombolysis with recombinant tissue plasminogen activator (rtPA) is a standard of care within 4.5 h of human stroke onset, suitable animal models that mimic cellular and molecular mechanisms of thrombosis and thrombolysis of stroke are required. By occluding the MCA with a fibrin-rich allogeneic clot, we previously developed an embolic model of MCA occlusion in the rat, which recapitulates the key components of thrombotic development and of thrombolytic therapy of rtPA observed from human ischemic stroke. Here we describe in detail the surgical procedures of our model, including preparing emboli from rat donors. These procedures can be typically completed within ∼30 min, and they are highly adaptable to other strains of rats, as well as mice, in both sexes. Thus, this model provides a powerful tool for translational stroke research.

Entities:  

Mesh:

Year:  2015        PMID: 25741989      PMCID: PMC4602402          DOI: 10.1038/nprot.2015.036

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  65 in total

1.  MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin.

Authors:  Guangliang Ding; Quan Jiang; Lian Li; Li Zhang; Zheng G Zhang; Swayamprava Panda; James R Ewing; Michael Chopp
Journal:  J Neurol Sci       Date:  2006-04-19       Impact factor: 3.181

2.  Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke.

Authors:  Victor J Marder; Dennis J Chute; Sidney Starkman; Anna M Abolian; Chelsea Kidwell; David Liebeskind; Bruce Ovbiagele; Fernando Vinuela; Gary Duckwiler; Reza Jahan; Paul M Vespa; Scott Selco; Venkatakrishna Rajajee; Doojin Kim; Nerses Sanossian; Jeffrey L Saver
Journal:  Stroke       Date:  2006-06-22       Impact factor: 7.914

3.  Embolic signals in unselected stroke patients: prevalence and diagnostic benefit.

Authors:  Holger Poppert; Suwad Sadikovic; Kerstin Sander; Oliver Wolf; Dirk Sander
Journal:  Stroke       Date:  2006-06-22       Impact factor: 7.914

4.  Therapeutic application of 20-kHz transcranial ultrasound in an embolic middle cerebral artery occlusion model in rats: safety concerns.

Authors:  Thomas Wilhelm-Schwenkmezger; Patrick Pittermann; Katharina Zajonz; Oliver Kempski; Marianne Dieterich; Max Nedelmann
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

5.  Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.

Authors:  Li Zhang; Zhenggang Zhang; Rui Lan Zhang; Yisheng Cui; Margot C LaPointe; Brian Silver; Michael Chopp
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

6.  Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.

Authors:  Li Zhang; Zheng Gang Zhang; Chunling Zhang; Rui Lan Zhang; Michael Chopp
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

Review 7.  Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.

Authors:  Giora Z Feuerstein; Margaret M Zaleska; Michael Krams; Xinkang Wang; Mark Day; Julia L Rutkowski; Seth P Finklestein; Menelas N Pangalos; Michael Poole; Gary L Stiles; Robert R Ruffolo; Frank L Walsh
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-20       Impact factor: 6.200

8.  Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage.

Authors:  Tong Cheng; Anthony L Petraglia; Zhang Li; Meenakshisundaram Thiyagarajan; Zhihui Zhong; Zhenhua Wu; Dong Liu; Sanjay B Maggirwar; Rashid Deane; José A Fernández; Barbra LaRue; John H Griffin; Michael Chopp; Berislav V Zlokovic
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

9.  Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.

Authors:  Yu Tanaka; Toshiyuki Marumo; Tomohiro Omura; Shigeru Yoshida
Journal:  Brain Res       Date:  2007-04-04       Impact factor: 3.252

10.  Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.

Authors:  Li Zhang; Zheng Gang Zhang; Xianshuang Liu; Ann Hozeska; Nancy Stagliano; William Riordan; Mei Lu; Michael Chopp
Journal:  Thromb Haemost       Date:  2006-01       Impact factor: 5.249

View more
  34 in total

1.  Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-08-29       Impact factor: 6.829

2.  NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.

Authors:  Chun-Chun Wei; Yuan-Yuan Kong; Xia Hua; Guo-Qiang Li; Si-Li Zheng; Ming-He Cheng; Pei Wang; Chao-Yu Miao
Journal:  Br J Pharmacol       Date:  2017-09-06       Impact factor: 8.739

Review 3.  Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.

Authors:  Tao Yan; Michael Chopp; Jieli Chen
Journal:  Neurosci Bull       Date:  2015-12-02       Impact factor: 5.203

4.  Intranasal salvinorin A improves neurological outcome in rhesus monkey ischemic stroke model using autologous blood clot.

Authors:  Longfei Wu; Di Wu; Jian Chen; Chunhua Chen; Tianqi Yao; Xiaoduo He; Yanqin Ma; Xinglong Zhi; Renyu Liu; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-02       Impact factor: 6.200

5.  Identification of Vigilin as a Potential Ischemia Biomarker by Brain Slice-Based Systematic Evolution of Ligands by Exponential Enrichment.

Authors:  Chao Liu; Wei Jiang; Xibin Tian; Peng Yang; Le Xiao; Jianglin Li; Liping Qiu; Haijun Tu; Weihong Tan
Journal:  Anal Chem       Date:  2019-05-01       Impact factor: 6.986

6.  Endovascular Ischemic Stroke Models in Nonhuman Primates.

Authors:  Di Wu; Ankush Chandra; Jian Chen; Yuchuan Ding; Xunming Ji
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

7.  Effect of recombinant human prourokinase on thrombolysis in a rabbit model of thromboembolic stroke.

Authors:  Chunhua Hao; Wenxia Ding; Xiangwei Xu; Qian Sun; Xinxin Li; Weiting Wang; Zhuanyou Zhao; Lida Tang
Journal:  Biomed Rep       Date:  2017-11-03

8.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.

Authors:  Chao Li; Li Zhang; Chunyang Wang; Hua Teng; Baoyan Fan; Michael Chopp; Zheng Gang Zhang
Journal:  Stroke       Date:  2019-08-07       Impact factor: 7.914

Review 9.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

Review 10.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Qing-Zhang Tuo; Jin-Jun Zou; Peng Lei
Journal:  J Mol Neurosci       Date:  2020-10-27       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.